DexCom Executive Sells $107K in Stock

Michael Jon Brown, EVP, sells 1,700 shares of the medical device company's stock.

Apr. 18, 2026 at 10:06am

Got story updates? Submit your updates here. ›

DexCom, Inc. (NASDAQ:DXCM) Executive Vice President Michael Jon Brown sold 1,700 shares of the firm's stock on April 15th, 2026 for a total value of $107,168. Following the sale, Brown directly owned 111,204 shares of the company's stock, valued at $7,010,300.16.

Why it matters

Insider stock sales can provide insight into a company's performance and the confidence of its leadership. DexCom is a leading medical device maker focused on continuous glucose monitoring systems, a rapidly growing market.

The details

The shares were sold at an average price of $63.04. The sale was disclosed in a filing with the SEC and was executed under a pre-arranged Rule 10b5-1 trading plan.

  • The stock sale occurred on Wednesday, April 15, 2026.

The players

Michael Jon Brown

Executive Vice President at DexCom, Inc.

DexCom, Inc.

A medical device company that develops, manufactures and distributes continuous glucose monitoring (CGM) systems for people with diabetes.

Got photos? Submit your photos here. ›

The takeaway

Insider transactions can provide clues about a company's future prospects, though the reasons behind this particular sale are not entirely clear. Investors will likely continue to monitor DexCom's performance and leadership activity as the CGM market evolves.